EE388 Economic Evaluation and Budget Impact of Brigatinib Versus Other ALK-Inhibitors for First-Line ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Treatment in the Brazilian Private Healthcare System.

Autor: Souza, P¹ (AUTHOR), Biglia, LV² (AUTHOR), Sales, ML² (AUTHOR)

Publikováno v: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS128-S128. 1p.

PRM89 - DATABASE ANALYSIS OF A PSP (PATIENT SUPPORT PROGRAM) FOR PATIENTS USING INTERFERON BETA-1A FOR RELAPSING MULTIPLE SCLEROSIS IN BRAZIL

Autor: Biglia, LV, Conceição, VB, Araújo, RV

Publikováno v: In Value in Health October 2018 21 Supplement 3:S370-S371

PDB5 - Cost-Minimization of Somatropin for GH Deficiency and Turner Syndrome Treatment from SUS Perspective

Autor: Souza, PV, Biglia, LV, Zanini, FE

Publikováno v: In Value in Health October-November 2017 20(9):A919-A920

PCN26 - Cetuximab in the First-Line Treatment of Ras Wild-Type Metastatic Colorectal Cancer with Liver-Limited Disease

Autor: Souza, PV, Zanini, FE, Biglia, LV, Kim, HS, Fahham, L

Publikováno v: In Value in Health October-November 2017 20(9):A875-A875

HTA criteria adopted in different models of public healthcare systems for orphan drugs: A scoping review.

Autor: Felippini A; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580 - Conj. das Químicas - Bloco 13 - Cidade Universitária Butantã, São Paulo, Brazil., Biglia LV; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580 - Conj. das Químicas - Bloco 13 - Cidade Universitária Butantã, São Paulo, Brazil., Lima TM; Department of Pharmacy and Pharmaceutical Administration, Faculty of Pharmacy, Fluminense Federal University, R. Dr. Mario Vianna, 523 - Santa Rosa, Niteroi, Brazil., Aguiar PM; Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580 - Conj. das Químicas - Bloco 13 - Cidade Universitária Butantã, São Paulo, Brazil. Electronic address: aguiar.pm@usp.br.

Publikováno v: Health policy (Amsterdam, Netherlands) [Health Policy] 2024 Jun; Vol. 144, pp. 105080. Date of Electronic Publication: 2024 May 06.